FDA Approves New Indication for ENVARSUS XR® (tacrolimus extended-release tablets)

NEXT STORY
ADMA Biologics Provides Regulatory Update on BIVIGAM® PAS Submissions
PREV STORY
Clearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of 2020-2030

author_avatar
NASDAQ Market News

Keryx Biopharmaceuticals Announces Presentation of Post-Hoc Data From Phase 3 Study of Auryxia® (Ferric Citrate) in Adults With Iron Deficiency Anemia and Non-dialysis Dependent Chronic Kidney Disease

Oral presentation showed impact of ferric citrate on a phosphate-regulating hormone, FGF23Poster presentation showed ...

author_avatar
NASDAQ Market News

ELSALYS BIOTECH ANNOUNCES THE REGISTRATION OF ITS DOCUMENT DE BASE

author_avatar
NASDAQ Market News